Fundraising Foxremynd
2 known investors
Find your way into remynd
Sign up to see every warm intro you have to remynd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the remynd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients with age-related neurodegenerative diseases such as Alzheimer's and Huntington's, and runs a discovery program targeting mitochondrial dysfunction in ALS. It also operates a contract research organization (CRO) that uses proprietary mouse models to help pharmaceutical companies in the US, Europe and Japan assess experimental neurodegenerative disease treatments.
Founders & leadership
FS
Floor StamCEO
GG
Gerard GriffioenCSO
SL
Sara LambrechtsHead of Finance
Investors · 2
Frequently asked questions
- What does remynd do?
- remynd develops first-in-class oral treatments to restore and preserve neuronal function in patients with age-related neurodegenerative diseases such as Alzheimer's and Huntington's, and runs a discovery program targeting mitochondrial dysfunction in ALS. It also operates a contract research organization (CRO) that uses proprietary mouse models to help pharmaceutical companies in the US, Europe and Japan assess experimental neurodegenerative disease treatments.
- Who are remynd's investors?
- remynd's investors include Korys, PMV.